01763.HK
China Isotope & Radiation Corporation
HKSE · Healthcare · Medical - Devices · CN
HKD 15.30
−2.61%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 14.6B | 7.0B | 7.6B | 6.6B | 6.1B |
| Cost of Revenue | 7.4B | 3.5B | 3.9B | 3.2B | 2.6B |
| Gross Profit | 7.2B | 3.5B | 3.7B | 3.5B | 3.5B |
| Operating Expenses | |||||
| R&D Expense | 594.4M | 294.1M | 300.3M | 306.1M | 300.5M |
| SG&A Expense | 4.7B | 2.3B | 2.3B | 2.4B | 2.4B |
| General & Admin Expense | 1.6B | 879.8M | 704.5M | 635.9M | 575.1M |
| Selling & Marketing Expense | 3.1B | 1.4B | 1.6B | 1.8B | 1.8B |
| Other Expenses | (56.0M) | (17.0M) | (32.0M) | (169.7M) | (50.6M) |
| Total Operating Expenses | 5.2B | 2.6B | 2.6B | 2.5B | 2.6B |
| Cost and Expenses | 12.6B | 6.1B | 6.5B | 5.7B | 5.2B |
| Operating Income (EBIT) | 2.0B | 916.2M | 1.1B | 941.6M | 914.0M |
| Non-Operating | |||||
| Interest Income | 54.9M | 16.8M | 29.6M | 31.0M | 45.3M |
| Interest Expense | 73.5M | 69.2M | 48.4M | 36.1M | 35.3M |
| Net Interest Income | (56.7M) | (52.3M) | (18.8M) | (5.2M) | 9.9M |
| Other Non-Op Income/Expense | 20.8M | 61.9M | (41.2M) | (19.2M) | 6.8M |
| Non-Operating Income (excl Interest) | 25.7M | — | 25.7M | (17.0M) | 39.1M |
| EBT (Pre-Tax Income) | 2.0B | 978.1M | 1.0B | 922.4M | 920.5M |
| Income Tax Expense | 496.5M | 330.8M | 165.7M | 146.3M | 165.9M |
| Bottom Line | |||||
| Net Income | 725.6M | 319.0M | 406.6M | 371.0M | 392.3M |
| Earnings from Cont. Ops | 1.5B | 647.3M | 879.5M | 776.1M | 755.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 725.6M | 319.0M | 406.6M | 371.0M | 392.3M |
| Per Share | |||||
| Basic EPS | HK$2.27 | HK$1.00 | HK$1.27 | HK$1.16 | HK$1.23 |
| Diluted EPS | HK$2.27 | HK$1.00 | HK$1.27 | HK$1.16 | HK$1.23 |
| Revenue Per Share | HK$45.57 | HK$21.89 | HK$23.68 | HK$20.74 | HK$19.21 |
| Shares | |||||
| Basic Shares Outstanding | 319.9M | 319.9M | 319.9M | 319.9M | 319.9M |
| Diluted Shares Outstanding | 319.9M | 319.9M | 319.9M | 319.9M | 319.9M |
| Profitability Metrics | |||||
| EBITDA | 2.5B | 1.2B | 1.3B | 1.2B | 1.1B |
| D&A | 476.2M | 253.0M | 223.2M | 264.4M | 182.8M |
| EBIT | 2.0B | 916.2M | 1.1B | 958.6M | 874.9M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025